Platelet-rich plasma, also known as autologous conditioned plasma, is a concentrate of platelet-rich plasma protein derived from whole blood, centrifuged to remove red blood cells. Evidence for benefit is mixed as of 2020, with some evidence for use in certain conditions and against use in other conditions. Platelet-rich plasma (PRP) therapy uses injections of a concentration of a patient's own platelets to accelerate the healing of injured tendons, ligaments, muscles and joints. In this way, PRP injections use each individual patient's own healing system to improve musculoskeletal problems.
Posters-Accepted Abstracts: Pediatrics & Therapeutics
Scientific Tracks Abstracts: Translational Medicine